Andrew Brackmann

Daniel Brennan

Matthew Sykes

Patrick Donnelly

Puneet Souda

Subhalaxmi Nambi

Tycho Peterson

Vijay Kumar

Douglas Schenkel

Jack Meehan

Andrew Cooper

Daniel Leonard

Daniel Arias

Eve Burstein

Mark Massaro

William Bonello

Catherine Ramsey

Catherine Schulte

Kyle Mikson

Luke Sergott

Sung Ji Nam

Brandon Couillard

Michael Ryskin

- A new study published in the *Journal of the National Cancer Institute* found that **Exact Sciences' Cologuard Plus™** provides the **most life-years gained with the fewest colonoscopies** among colorectal cancer screening strategies.  **[1124140_cf317bd3d31f49cc80f745c0e55a7b37_0]** 
- The study, which used methodologies adopted by the **United States Preventive Services Task Force (USPSTF)**, concluded that **Cologuard Plus**, a **triennial next-generation multitarget stool DNA (mt-sDNA) test**, was the **only noninvasive screening option** shown to be efficient at guideline-recommended intervals and age ranges.  **[1124140_cf317bd3d31f49cc80f745c0e55a7b37_0]** 
- **Cologuard Plus** offers **high performance** with a **95% sensitivity for CRC** and **94% specificity** in the U.S. screening age population, making it an important tool to improve colorectal cancer outcomes and preserve limited colonoscopy capacity.  **[1124140_cf317bd3d31f49cc80f745c0e55a7b37_1]**  It is an **FDA-approved** first-line, noninvasive colorectal cancer screening option for average-risk adults aged 45 or older.  **[1124140_cf317bd3d31f49cc80f745c0e55a7b37_2]**

Exact Sciences Announces Positive Study Results for Cologuard Plus

EXACT SCIENCES (EXAS)